 | • レポートコード：QYR9NV14010 • 出版社/出版日：QYResearch / 2019年11月16日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：材料・化学 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ワクチンコンジュゲートの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、一価、多価、その他に、用途別には、インフルエンザ、髄膜炎菌、肺炎球菌、その他にセグメント区分し、ワクチンコンジュゲートの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ワクチンコンジュゲートの世界市場概要 ・ワクチンコンジュゲートの製造コスト構成分析 ・ワクチンコンジュゲートの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ワクチンコンジュゲートの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ワクチンコンジュゲートのセグメント分析（種類別） （一価、多価、その他） ・ワクチンコンジュゲートのセグメント分析（用途別） （インフルエンザ、髄膜炎菌、肺炎球菌、その他） ・ワクチンコンジュゲートの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Merck & Co., Inc.、GlaxoSmithKline plc.、SutroVax Inc.、Fablife.、Pfizer、Sinovac Biotech Ltd.、Sanofi Pasteur SA.、） ・ワクチンコンジュゲートの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Vaccine Conjugate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Vaccine Conjugate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Vaccine Conjugate market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Vaccine Conjugate in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Vaccine Conjugate manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck & Co., Inc.
GlaxoSmithKline plc.
SutroVax Inc.
Fablife.
Pfizer
Sinovac Biotech Ltd.
Sanofi Pasteur SA.
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Monovalent
Multivalent
Others
Segment by Application
Influenza
Meningococcal
Pneumococcal
Others
Table of Contents
Executive Summary
1 Industry Overview of Vaccine Conjugate
1.1 Definition of Vaccine Conjugate
1.2 Vaccine Conjugate Segment by Type
1.2.1 Global Vaccine Conjugate Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Monovalent
1.2.3 Multivalent
1.2.4 Others
1.3 Vaccine Conjugate Segment by Applications
1.3.1 Global Vaccine Conjugate Consumption Comparison by Applications (2014-2025)
1.3.2 Influenza
1.3.3 Meningococcal
1.3.4 Pneumococcal
1.3.5 Others
1.4 Global Vaccine Conjugate Overall Market
1.4.1 Global Vaccine Conjugate Revenue (2014-2025)
1.4.2 Global Vaccine Conjugate Production (2014-2025)
1.4.3 North America Vaccine Conjugate Status and Prospect (2014-2025)
1.4.4 Europe Vaccine Conjugate Status and Prospect (2014-2025)
1.4.5 China Vaccine Conjugate Status and Prospect (2014-2025)
1.4.6 Japan Vaccine Conjugate Status and Prospect (2014-2025)
1.4.7 Southeast Asia Vaccine Conjugate Status and Prospect (2014-2025)
1.4.8 India Vaccine Conjugate Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Vaccine Conjugate
2.3 Manufacturing Process Analysis of Vaccine Conjugate
2.4 Industry Chain Structure of Vaccine Conjugate
3 Development and Manufacturing Plants Analysis of Vaccine Conjugate
3.1 Capacity and Commercial Production Date
3.2 Global Vaccine Conjugate Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Vaccine Conjugate
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Vaccine Conjugate Production and Capacity Analysis
4.2 Vaccine Conjugate Revenue Analysis
4.3 Vaccine Conjugate Price Analysis
4.4 Market Concentration Degree
5 Vaccine Conjugate Regional Market Analysis
5.1 Vaccine Conjugate Production by Regions
5.1.1 Global Vaccine Conjugate Production by Regions
5.1.2 Global Vaccine Conjugate Revenue by Regions
5.2 Vaccine Conjugate Consumption by Regions
5.3 North America Vaccine Conjugate Market Analysis
5.3.1 North America Vaccine Conjugate Production
5.3.2 North America Vaccine Conjugate Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Vaccine Conjugate Import and Export
5.4 Europe Vaccine Conjugate Market Analysis
5.4.1 Europe Vaccine Conjugate Production
5.4.2 Europe Vaccine Conjugate Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Vaccine Conjugate Import and Export
5.5 China Vaccine Conjugate Market Analysis
5.5.1 China Vaccine Conjugate Production
5.5.2 China Vaccine Conjugate Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Vaccine Conjugate Import and Export
5.6 Japan Vaccine Conjugate Market Analysis
5.6.1 Japan Vaccine Conjugate Production
5.6.2 Japan Vaccine Conjugate Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Vaccine Conjugate Import and Export
5.7 Southeast Asia Vaccine Conjugate Market Analysis
5.7.1 Southeast Asia Vaccine Conjugate Production
5.7.2 Southeast Asia Vaccine Conjugate Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Vaccine Conjugate Import and Export
5.8 India Vaccine Conjugate Market Analysis
5.8.1 India Vaccine Conjugate Production
5.8.2 India Vaccine Conjugate Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Vaccine Conjugate Import and Export
6 Vaccine Conjugate Segment Market Analysis (by Type)
6.1 Global Vaccine Conjugate Production by Type
6.2 Global Vaccine Conjugate Revenue by Type
6.3 Vaccine Conjugate Price by Type
7 Vaccine Conjugate Segment Market Analysis (by Application)
7.1 Global Vaccine Conjugate Consumption by Application
7.2 Global Vaccine Conjugate Consumption Market Share by Application (2014-2019)
8 Vaccine Conjugate Major Manufacturers Analysis
8.1 Merck & Co., Inc.
8.1.1 Merck & Co., Inc. Vaccine Conjugate Production Sites and Area Served
8.1.2 Merck & Co., Inc. Product Introduction, Application and Specification
8.1.3 Merck & Co., Inc. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 GlaxoSmithKline plc.
8.2.1 GlaxoSmithKline plc. Vaccine Conjugate Production Sites and Area Served
8.2.2 GlaxoSmithKline plc. Product Introduction, Application and Specification
8.2.3 GlaxoSmithKline plc. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 SutroVax Inc.
8.3.1 SutroVax Inc. Vaccine Conjugate Production Sites and Area Served
8.3.2 SutroVax Inc. Product Introduction, Application and Specification
8.3.3 SutroVax Inc. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Fablife.
8.4.1 Fablife. Vaccine Conjugate Production Sites and Area Served
8.4.2 Fablife. Product Introduction, Application and Specification
8.4.3 Fablife. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pfizer
8.5.1 Pfizer Vaccine Conjugate Production Sites and Area Served
8.5.2 Pfizer Product Introduction, Application and Specification
8.5.3 Pfizer Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Sinovac Biotech Ltd.
8.6.1 Sinovac Biotech Ltd. Vaccine Conjugate Production Sites and Area Served
8.6.2 Sinovac Biotech Ltd. Product Introduction, Application and Specification
8.6.3 Sinovac Biotech Ltd. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Sanofi Pasteur SA.
8.7.1 Sanofi Pasteur SA. Vaccine Conjugate Production Sites and Area Served
8.7.2 Sanofi Pasteur SA. Product Introduction, Application and Specification
8.7.3 Sanofi Pasteur SA. Vaccine Conjugate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
9 Development Trend of Analysis of Vaccine Conjugate Market
9.1 Global Vaccine Conjugate Market Trend Analysis
9.1.1 Global Vaccine Conjugate Market Size (Volume and Value) Forecast 2019-2025
9.2 Vaccine Conjugate Regional Market Trend
9.2.1 North America Vaccine Conjugate Forecast 2019-2025
9.2.2 Europe Vaccine Conjugate Forecast 2019-2025
9.2.3 China Vaccine Conjugate Forecast 2019-2025
9.2.4 Japan Vaccine Conjugate Forecast 2019-2025
9.2.5 Southeast Asia Vaccine Conjugate Forecast 2019-2025
9.2.6 India Vaccine Conjugate Forecast 2019-2025
9.3 Vaccine Conjugate Market Trend (Product Type)
9.4 Vaccine Conjugate Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Vaccine Conjugate Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Vaccine Conjugate
Table Global Vaccine Conjugate Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Vaccine Conjugate Production Market Share by Types in 2018
Figure Monovalent Product Picture
Figure Multivalent Product Picture
Figure Others Product Picture
Table Global Vaccine Conjugate Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Vaccine Conjugate Consumption Market Share by Applications in 2018
Figure Influenza
Figure Meningococcal
Figure Pneumococcal
Figure Others
Figure Global Vaccine Conjugate Revenue (Million USD) (2014-2025)
Figure Global Vaccine Conjugate Production (K MT) (2014-2025)
Figure North America Vaccine Conjugate Market Size (Million USD) (2014-2025)
Figure Europe Vaccine Conjugate Market Size (Million USD) (2014-2025)
Figure China Vaccine Conjugate Market Size (Million USD) (2014-2025)
Figure Japan Vaccine Conjugate Market Size (Million USD) (2014-2025)
Figure Southeast Asia Vaccine Conjugate Market Size (Million USD) (2014-2025)
Figure India Vaccine Conjugate Market Size (Million USD) (2014-2025)
Table Vaccine Conjugate Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Vaccine Conjugate in 2018
Figure Manufacturing Process Analysis of Vaccine Conjugate
Figure Industry Chain Structure of Vaccine Conjugate
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Vaccine Conjugate Manufacturing Plants Distribution
Table Vaccine Conjugate Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Vaccine Conjugate Capacity (K MT) of Major Manufacturers (2014-2019)
Table Vaccine Conjugate Production (K MT) of Major Manufacturers (2014-2019)
Table Vaccine Conjugate Production Market Share of Major Manufacturers (2014-2019)
Figure Vaccine Conjugate Production Share by Manufacturers in 2018
Table Vaccine Conjugate Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Vaccine Conjugate Revenue Market Share of Major Manufacturers (2014-2019)
Figure Vaccine Conjugate Revenue Share by Manufacturers in 2018
Table Vaccine Conjugate Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Vaccine Conjugate Production by Regions 2014-2019 (K MT)
Table Global Vaccine Conjugate Production Market Share by Regions 2014-2019
Figure Global Vaccine Conjugate Production Market Share by Regions in 2018
Table Global Vaccine Conjugate Revenue by Regions 2014-2019 (Million USD)
Table Global Vaccine Conjugate Revenue Market Share by Regions 2014-2019
Figure Global Vaccine Conjugate Revenue Market Share by Regions in 2018
Table Global Vaccine Conjugate Consumption by Regions 2014-2019 (K MT)
Table Global Vaccine Conjugate Consumption Market Share by Regions 2014-2019
Figure North America Vaccine Conjugate Production Growth Rate 2014-2019 (K MT)
Figure North America Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD)
Table North America Vaccine Conjugate Production, Consumption Import and Export (K MT)
Figure Europe Vaccine Conjugate Production Growth Rate 2014-2019 (K MT)
Figure Europe Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Vaccine Conjugate Production, Consumption Import and Export (K MT)
Figure China Vaccine Conjugate Production Growth Rate 2014-2019 (K MT)
Figure China Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD)
Table China Vaccine Conjugate Production, Consumption Import and Export (K MT)
Figure Japan Vaccine Conjugate Production Growth Rate 2014-2019 (K MT)
Figure Japan Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Vaccine Conjugate Production, Consumption Import and Export (K MT)
Figure Southeast Asia Vaccine Conjugate Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Vaccine Conjugate Production, Consumption Import and Export (K MT)
Figure India Vaccine Conjugate Production Growth Rate 2014-2019 (K MT)
Figure India Vaccine Conjugate Revenue Growth Rate 2014-2019 (Million USD)
Table India Vaccine Conjugate Production, Consumption Import and Export (K MT)
Figure Global Consumption Vaccine Conjugate Market Share by Application (2014-2019)
Figure Global Value (Consumption) Vaccine Conjugate Market Share by Application (2014-2019)
Table Merck & Co., Inc. Vaccine Conjugate Production Sites and Area Served
Table Merck & Co., Inc. Vaccine Conjugate Product Introduction, Application and Specification
Table Merck & Co., Inc. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Merck & Co., Inc. Vaccine Conjugate Production Growth Rate (2014-2019)
Table Merck & Co., Inc. Vaccine Conjugate Production Market Share (2014-2019)
Figure Merck & Co., Inc. Vaccine Conjugate Revenue Market Share (2014-2019)
Table Merck & Co., Inc. Vaccine Conjugate Main Business and Markets Served
Table GlaxoSmithKline plc. Vaccine Conjugate Production Sites and Area Served
Table GlaxoSmithKline plc. Vaccine Conjugate Product Introduction, Application and Specification
Table GlaxoSmithKline plc. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline plc. Vaccine Conjugate Production Growth Rate (2014-2019)
Table GlaxoSmithKline plc. Vaccine Conjugate Production Market Share (2014-2019)
Figure GlaxoSmithKline plc. Vaccine Conjugate Revenue Market Share (2014-2019)
Table GlaxoSmithKline plc. Vaccine Conjugate Main Business and Markets Served
Table SutroVax Inc. Vaccine Conjugate Production Sites and Area Served
Table SutroVax Inc. Vaccine Conjugate Product Introduction, Application and Specification
Table SutroVax Inc. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table SutroVax Inc. Vaccine Conjugate Production Growth Rate (2014-2019)
Table SutroVax Inc. Vaccine Conjugate Production Market Share (2014-2019)
Figure SutroVax Inc. Vaccine Conjugate Revenue Market Share (2014-2019)
Table SutroVax Inc. Vaccine Conjugate Main Business and Markets Served
Table Fablife. Vaccine Conjugate Production Sites and Area Served
Table Fablife. Vaccine Conjugate Product Introduction, Application and Specification
Table Fablife. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Fablife. Vaccine Conjugate Production Growth Rate (2014-2019)
Table Fablife. Vaccine Conjugate Production Market Share (2014-2019)
Figure Fablife. Vaccine Conjugate Revenue Market Share (2014-2019)
Table Fablife. Vaccine Conjugate Main Business and Markets Served
Table Pfizer Vaccine Conjugate Production Sites and Area Served
Table Pfizer Vaccine Conjugate Product Introduction, Application and Specification
Table Pfizer Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Vaccine Conjugate Production Growth Rate (2014-2019)
Table Pfizer Vaccine Conjugate Production Market Share (2014-2019)
Figure Pfizer Vaccine Conjugate Revenue Market Share (2014-2019)
Table Pfizer Vaccine Conjugate Main Business and Markets Served
Table Sinovac Biotech Ltd. Vaccine Conjugate Production Sites and Area Served
Table Sinovac Biotech Ltd. Vaccine Conjugate Product Introduction, Application and Specification
Table Sinovac Biotech Ltd. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Sinovac Biotech Ltd. Vaccine Conjugate Production Growth Rate (2014-2019)
Table Sinovac Biotech Ltd. Vaccine Conjugate Production Market Share (2014-2019)
Figure Sinovac Biotech Ltd. Vaccine Conjugate Revenue Market Share (2014-2019)
Table Sinovac Biotech Ltd. Vaccine Conjugate Main Business and Markets Served
Table Sanofi Pasteur SA. Vaccine Conjugate Production Sites and Area Served
Table Sanofi Pasteur SA. Vaccine Conjugate Product Introduction, Application and Specification
Table Sanofi Pasteur SA. Vaccine Conjugate Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Pasteur SA. Vaccine Conjugate Production Growth Rate (2014-2019)
Table Sanofi Pasteur SA. Vaccine Conjugate Production Market Share (2014-2019)
Figure Sanofi Pasteur SA. Vaccine Conjugate Revenue Market Share (2014-2019)
Table Sanofi Pasteur SA. Vaccine Conjugate Main Business and Markets Served
Figure Global Vaccine Conjugate Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Vaccine Conjugate Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Vaccine Conjugate Sales Price (USD/MT) Forecast 2019-2025
Figure North America Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Vaccine Conjugate Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Vaccine Conjugate Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Vaccine Conjugate by Type (2019-2025)
Table Global Consumption (K MT) of Vaccine Conjugate by Application (2019-2025)
Table Vaccine Conjugate Distributors List
Table Vaccine Conjugate Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ワクチンコンジュゲートのグローバル市場調査 2019年 The global Vaccine Conjugate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Vaccine Conjugate volume and value at global level, regional level and company level. From a global perspective, this rep…- 世界及び中国のヘモフィルス-インフルエンザb型菌ワクチン市場2018 The 'Global and Chinese Haemophilus Influenzae Type b Conjugate Vaccine Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Haemophilus Influenzae Type b Conjugate Vaccine industry with a focus on the Chinese market. The report provides…
- ワクチン接種の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein. Scope of the Report: This report focuses on the Conjugate Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middl…
- 7価肺炎球菌ワクチンのグローバル市場調査 2019年 The global 7-Valent Pneumococcal Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 7-Valent Pneumococcal Vaccine volume and value at global level, regional level and company level. From a glob…
- 7価肺炎球菌ワクチンのグローバル市場調査 2019年 The global 7-Valent Pneumococcal Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on 7-Valent Pneumococcal Vaccine volume and value at global level, regional level and company level. From a glob…